Corbus Pharmaceuticals Ownership 2024 | Who Owns Corbus Pharmaceuticals Now?
Institutional Ownership
0.00%
Insider Ownership
0.76%
Retail Ownership
99.24%
Institutional Holders
1.00
Corbus Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| IFP ADVISORS, INC | - | - | - | -100 | -100.00% | - | Jun 30, 2023 |
Corbus Pharmaceuticals's largest institutional shareholder is IFP ADVISORS, INC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| IFP ADVISORS, INC | - | - | - | -100 | -100.00% | - | Jun 30, 2023 |
The largest Corbus Pharmaceuticals shareholder by % of total assets is IFP ADVISORS, INC. The company owns 0.00 shares of Corbus Pharmaceuticals (CRBP), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| IFP ADVISORS, INC | - | - | - | -100 | -100.00% | - | Jun 30, 2023 |
As of Jun 30 2023, Corbus Pharmaceuticals's largest institutional buyer is IFP ADVISORS, INC. The company purchased -0.10K stocks of CRBP, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| IFP ADVISORS, INC | - | - | - | -100 | -100.00% | - | Jun 30, 2023 |
As of Jun 30 2023, Corbus Pharmaceuticals's biggest institutional seller is IFP ADVISORS, INC. The company sold -0.10K shares of CRBP, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| IFP ADVISORS, INC | - | - | - | -100 | -100.00% | - | Jun 30, 2023 |
Corbus Pharmaceuticals's largest sold out institutional shareholder by shares sold is IFP ADVISORS, INC, sold -0.10K shares, valued at -, as of undefined.
Corbus Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| AMERICAN GROWTH FUND INC | 6.14% | 5,880 | - | - | Jul 31, 2023 |
| ETF Managers Trust | 0.61% | 4,710,319 | - | - | Dec 31, 2023 |
| GENERAL AMERICAN INVESTORS CO INC | 0.43% | 600,000 | - | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.33% | 154,310 | - | - | Mar 31, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.30% | 259,171 | - | - | Mar 31, 2024 |
| Spinnaker ETF Series | 0.15% | 56,776 | - | - | Mar 31, 2024 |
| AdvisorShares Trust | 0.12% | 479,453 | - | - | Mar 28, 2024 |
| BlackRock Health Sciences Trust | 0.12% | 29,797 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.08% | 200,000 | - | - | Mar 28, 2024 |
| Global X Funds | 0.08% | 3,641,113 | - | - | Jan 31, 2024 |
| Fidelity Commonwealth Trust II | 0.04% | 248,721 | - | - | Aug 31, 2023 |
| ETFis Series Trust I | 0.03% | 42,358 | - | - | Jan 31, 2024 |
| ETF Series Solutions | 0.02% | 537,236 | - | - | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.02% | 1,479,867 | - | - | Feb 29, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 11,734 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 110,272 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.01% | 135,883 | - | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.01% | 126,397 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 3,887,860 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,738 | - | - | Mar 31, 2024 |
| Cambria ETF Trust | 0.00% | 41,800 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 923,701 | - | - | Feb 29, 2024 |
| SSGA FUNDS | 0.00% | 1,749 | - | - | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 112,969 | - | - | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 445,780 | - | - | Jan 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 99,416 | - | - | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 24,820 | - | - | Mar 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 9,744 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 5,006 | - | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 28,722 | - | - | Jan 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 616 | - | - | Apr 30, 2021 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 35,902 | - | - | Mar 31, 2024 |
| Investment Managers Series Trust II | 0.00% | 10,800 | - | - | Jan 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 474,283 | - | - | Feb 29, 2024 |
| VANGUARD WORLD FUND | 0.00% | 182,514 | - | - | Feb 29, 2024 |
| PFM Multi-Manager Series Trust | 0.00% | 600 | - | - | Dec 31, 2023 |
| Virtus Strategy Trust | 0.00% | 14,071 | - | - | Mar 28, 2024 |
| AdvisorShares Trust | 0.00% | 2,555 | - | - | Mar 28, 2024 |
| Pacer Funds Trust | 0.00% | 28,987 | - | - | Jan 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 147,101 | - | - | Jan 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 28,222 | - | - | Feb 29, 2024 |
| SPDR SERIES TRUST | 0.00% | 15,304,430 | - | - | Mar 31, 2024 |
| NEW COVENANT FUNDS | 0.00% | 1,468 | - | - | Dec 31, 2023 |
| NORTHERN FUNDS | 0.00% | 47,470 | - | - | Mar 28, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 1,977 | - | - | Aug 31, 2023 |
| Meeder Funds | 0.00% | 1,314 | - | - | Mar 31, 2024 |
| ADVISORS' INNER CIRCLE FUND | 0.00% | 6,417 | - | - | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 708 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 14,214 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 20,661 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 672,975 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 56,310 | - | - | Mar 31, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 48,280 | - | - | Jan 31, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 15,967 | - | - | Mar 28, 2024 |
| ProFunds | 0.00% | 1,667 | - | - | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 12,901 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 36,459 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 251,477 | - | - | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 12,520 | - | - | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 2,500 | - | - | Mar 28, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 88,396 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 3,313 | - | - | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 10,431 | - | - | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.00% | 662 | - | - | Mar 31, 2024 |
| Virtus Investment Trust | 0.00% | 1,864 | - | - | Mar 28, 2024 |
| TIAA-CREF FUNDS | 0.00% | 162,273 | - | - | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 4,967 | - | - | Feb 29, 2024 |
| HC CAPITAL TRUST | 0.00% | 1,495 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 3,572 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 780 | - | - | Feb 29, 2024 |
| Brighthouse Funds Trust II | 0.00% | 31,148 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 32,150 | 10,133 | 46.02% | Jan 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 74,692 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 22,528 | - | - | Mar 31, 2024 |
| Advisors' Inner Circle Fund II | 0.00% | 15,200 | - | - | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 36,580 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 5,714 | - | - | Jan 31, 2024 |
| iSHARES TRUST | 0.00% | 190,991 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 11,021 | - | - | Jan 31, 2024 |
| iShares U.S. ETF Trust | 0.00% | 1,232 | - | - | Jan 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 9,394 | - | - | Dec 31, 2023 |
| PACIFIC SELECT FUND | 0.00% | 30,158 | - | - | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 29,608 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 1,876 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 486 | - | - | Jan 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 13,125 | - | - | Feb 29, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 8,897 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 6,755 | - | - | Mar 28, 2024 |
| John Hancock Funds II | 0.00% | 13,709 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 15,800 | - | - | Feb 29, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 41 | - | - | Jan 31, 2024 |
Corbus Pharmaceuticals's largest mutual fund holder by % of total assets is "AMERICAN GROWTH FUND INC", owning 5.88K shares, compromising 6.14% of its total assets.
Corbus Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 23 | 1 | -98.41% |
| 31 Dec, 22 | 63 | 5.00% |
| 30 Sep, 22 | 60 | -9.09% |
| 30 Jun, 22 | 66 | -8.33% |
| 31 Mar, 22 | 72 | -12.20% |
| 31 Dec, 21 | 82 | -10.87% |
| 30 Sep, 21 | 92 | -10.68% |
| 30 Jun, 21 | 103 | -12.71% |
| 31 Mar, 21 | 118 | 2.61% |
| 31 Dec, 20 | 115 | -19.01% |
| 30 Sep, 20 | 142 | -10.69% |
| 30 Jun, 20 | 159 | 34.75% |
| 31 Mar, 20 | 118 | 6.31% |
| 31 Dec, 19 | 111 | 0.91% |
| 30 Sep, 19 | 110 | -1.79% |
| 30 Jun, 19 | 112 | 0.90% |
| 31 Mar, 19 | 111 | 20.65% |
| 31 Dec, 18 | 92 | -3.16% |
| 30 Sep, 18 | 95 | 5.56% |
| 30 Jun, 18 | 90 | 4.65% |
| 31 Mar, 18 | 86 | -7.53% |
| 31 Dec, 17 | 93 | 25.68% |
| 30 Sep, 17 | 74 | -2.63% |
| 30 Jun, 17 | 76 | 11.76% |
| 31 Mar, 17 | 68 | 21.43% |
| 31 Dec, 16 | 56 | 33.33% |
| 30 Sep, 16 | 42 | 68.00% |
| 30 Jun, 16 | 25 | 13.64% |
| 31 Mar, 16 | 22 | - |
| 31 Dec, 15 | 22 | 15.79% |
| 30 Sep, 15 | 19 | 35.71% |
| 30 Jun, 15 | 14 | - |
As of 31 Mar 23, 1 institutions are holding Corbus Pharmaceuticals's shares, representing a decrease of -98.41% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 23 | 100 | -100.00% |
| 31 Dec, 22 | 11,889,537 | -49.17% |
| 30 Sep, 22 | 23,391,533 | -26.54% |
| 30 Jun, 22 | 31,842,077 | -15.02% |
| 31 Mar, 22 | 37,471,809 | -15.87% |
| 31 Dec, 21 | 44,542,412 | -0.47% |
| 30 Sep, 21 | 44,753,486 | -9.71% |
| 30 Jun, 21 | 49,564,228 | 13.20% |
| 31 Mar, 21 | 43,783,125 | 11.13% |
| 31 Dec, 20 | 39,399,212 | -30.20% |
| 30 Sep, 20 | 56,446,120 | 23.67% |
| 30 Jun, 20 | 45,644,278 | 29.17% |
| 31 Mar, 20 | 35,337,472 | 14.22% |
| 31 Dec, 19 | 30,938,384 | -3.06% |
| 30 Sep, 19 | 31,914,216 | -1.43% |
| 30 Jun, 19 | 32,375,916 | 36.98% |
| 31 Mar, 19 | 23,635,390 | -8.86% |
| 31 Dec, 18 | 25,933,958 | 18.05% |
| 30 Sep, 18 | 21,968,398 | -9.98% |
| 30 Jun, 18 | 24,405,066 | 3.58% |
| 31 Mar, 18 | 23,562,012 | 11.42% |
| 31 Dec, 17 | 21,146,303 | 38.43% |
| 30 Sep, 17 | 15,275,442 | -4.28% |
| 30 Jun, 17 | 15,958,319 | 13.93% |
| 31 Mar, 17 | 14,007,167 | 7.63% |
| 31 Dec, 16 | 13,013,996 | 10.31% |
| 30 Sep, 16 | 11,797,557 | 15.26% |
| 30 Jun, 16 | 10,235,984 | 97.88% |
| 31 Mar, 16 | 5,172,793 | 3.33% |
| 31 Dec, 15 | 5,006,201 | -46.78% |
| 30 Sep, 15 | 9,406,757 | 203.62% |
| 30 Jun, 15 | 3,098,233 | - |
Corbus Pharmaceuticals (CRBP) has 100.00 shares outstanding as of 31 Mar 23, down -100.00% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 23 | 0.00% | 0.00% |
| 31 Dec, 22 | 9.50% | 2.72% |
| 30 Sep, 22 | 18.67% | 2.89% |
| 30 Jun, 22 | 25.42% | 2.84% |
| 31 Mar, 22 | 29.92% | 2.28% |
| 31 Dec, 21 | 36.22% | 2.83% |
| 30 Sep, 21 | 35.74% | 1.97% |
| 30 Jun, 21 | 42.59% | 3.01% |
| 31 Mar, 21 | 37.63% | 1.84% |
| 31 Dec, 20 | 45.18% | 0.95% |
| 30 Sep, 20 | 68.94% | 1.81% |
| 30 Jun, 20 | 61.78% | 2.37% |
| 31 Mar, 20 | 51.01% | 2.18% |
| 31 Dec, 19 | 48.42% | 1.99% |
| 30 Sep, 19 | 49.36% | 1.96% |
| 30 Jun, 19 | 50.16% | 3.42% |
| 31 Mar, 19 | 38.32% | 1.87% |
| 31 Dec, 18 | 45.31% | 3.07% |
| 30 Sep, 18 | 38.39% | 2.11% |
| 30 Jun, 18 | 42.70% | 2.44% |
| 31 Mar, 18 | 41.80% | 2.35% |
| 31 Dec, 17 | 42.14% | 4.56% |
| 30 Sep, 17 | 30.42% | 3.01% |
| 30 Jun, 17 | 31.79% | 3.49% |
| 31 Mar, 17 | 30.20% | 3.02% |
| 31 Dec, 16 | 31.64% | 4.36% |
| 30 Sep, 16 | 26.95% | 3.86% |
| 30 Jun, 16 | 26.42% | 13.96% |
| 31 Mar, 16 | 13.76% | 7.76% |
| 31 Dec, 15 | 13.31% | 1.82% |
| 30 Sep, 15 | 27.05% | 20.40% |
| 30 Jun, 15 | 11.52% | - |
As of 31 Mar 23, Corbus Pharmaceuticals is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 31 Dec 22.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 23 | - | -100.00% |
| 31 Dec, 22 | 23 | 27.78% |
| 30 Sep, 22 | 18 | -33.33% |
| 30 Jun, 22 | 27 | 3.85% |
| 31 Mar, 22 | 26 | -25.71% |
| 31 Dec, 21 | 35 | 6.06% |
| 30 Sep, 21 | 33 | -13.16% |
| 30 Jun, 21 | 38 | -34.48% |
| 31 Mar, 21 | 58 | 34.88% |
| 31 Dec, 20 | 43 | -34.85% |
| 30 Sep, 20 | 66 | -30.53% |
| 30 Jun, 20 | 95 | 26.67% |
| 31 Mar, 20 | 75 | 53.06% |
| 31 Dec, 19 | 49 | 25.64% |
| 30 Sep, 19 | 39 | -23.53% |
| 30 Jun, 19 | 51 | -23.88% |
| 31 Mar, 19 | 67 | 71.79% |
| 31 Dec, 18 | 39 | - |
| 30 Sep, 18 | 39 | -18.75% |
| 30 Jun, 18 | 48 | 2.13% |
| 31 Mar, 18 | 47 | -20.34% |
| 31 Dec, 17 | 59 | 51.28% |
| 30 Sep, 17 | 39 | -18.75% |
| 30 Jun, 17 | 48 | 17.07% |
| 31 Mar, 17 | 41 | 13.89% |
| 31 Dec, 16 | 36 | 12.50% |
| 30 Sep, 16 | 32 | 68.42% |
| 30 Jun, 16 | 19 | 137.50% |
| 31 Mar, 16 | 8 | - |
| 31 Dec, 15 | 8 | -50.00% |
| 30 Sep, 15 | 16 | 14.29% |
| 30 Jun, 15 | 14 | - |
- institutional shareholders have increased their position in CRBP stock as of 31 Mar 23 compared to 23 in the previous quarter (a -100.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 23 | 1 | -93.75% |
| 31 Dec, 22 | 16 | 14.29% |
| 30 Sep, 22 | 14 | - |
| 30 Jun, 22 | 14 | -36.36% |
| 31 Mar, 22 | 22 | 10.00% |
| 31 Dec, 21 | 20 | -23.08% |
| 30 Sep, 21 | 26 | -21.21% |
| 30 Jun, 21 | 33 | 37.50% |
| 31 Mar, 21 | 24 | -42.86% |
| 31 Dec, 20 | 42 | 13.51% |
| 30 Sep, 20 | 37 | 37.04% |
| 30 Jun, 20 | 27 | 68.75% |
| 31 Mar, 20 | 16 | -44.83% |
| 31 Dec, 19 | 29 | -17.14% |
| 30 Sep, 19 | 35 | 16.67% |
| 30 Jun, 19 | 30 | 87.50% |
| 31 Mar, 19 | 16 | -27.27% |
| 31 Dec, 18 | 22 | - |
| 30 Sep, 18 | 22 | 15.79% |
| 30 Jun, 18 | 19 | 18.75% |
| 31 Mar, 18 | 16 | - |
| 31 Dec, 17 | 16 | -5.88% |
| 30 Sep, 17 | 17 | 142.86% |
| 30 Jun, 17 | 7 | -30.00% |
| 31 Mar, 17 | 10 | 25.00% |
| 31 Dec, 16 | 8 | 100.00% |
| 30 Sep, 16 | 4 | 100.00% |
| 30 Jun, 16 | 2 | -50.00% |
| 31 Mar, 16 | 4 | -20.00% |
| 31 Dec, 15 | 5 | 150.00% |
| 30 Sep, 15 | 2 | - |
| 30 Jun, 15 | - | - |
1 institutional shareholders have reduced their position in CRBP stock as of 31 Mar 23 compared to 16 in the previous quarter (a -93.75% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 23 | 1 | -98.41% | 100 | -100.00% | 0.00% | 0.00% | - | -100.00% | 1 | -93.75% |
| 31 Dec, 22 | 63 | 5.00% | 11,889,537 | -49.17% | 9.50% | 2.72% | 23 | 27.78% | 16 | 14.29% |
| 30 Sep, 22 | 60 | -9.09% | 23,391,533 | -26.54% | 18.67% | 2.89% | 18 | -33.33% | 14 | - |
| 30 Jun, 22 | 66 | -8.33% | 31,842,077 | -15.02% | 25.42% | 2.84% | 27 | 3.85% | 14 | -36.36% |
| 31 Mar, 22 | 72 | -12.20% | 37,471,809 | -15.87% | 29.92% | 2.28% | 26 | -25.71% | 22 | 10.00% |
| 31 Dec, 21 | 82 | -10.87% | 44,542,412 | -0.47% | 36.22% | 2.83% | 35 | 6.06% | 20 | -23.08% |
| 30 Sep, 21 | 92 | -10.68% | 44,753,486 | -9.71% | 35.74% | 1.97% | 33 | -13.16% | 26 | -21.21% |
| 30 Jun, 21 | 103 | -12.71% | 49,564,228 | 13.20% | 42.59% | 3.01% | 38 | -34.48% | 33 | 37.50% |
| 31 Mar, 21 | 118 | 2.61% | 43,783,125 | 11.13% | 37.63% | 1.84% | 58 | 34.88% | 24 | -42.86% |
| 31 Dec, 20 | 115 | -19.01% | 39,399,212 | -30.20% | 45.18% | 0.95% | 43 | -34.85% | 42 | 13.51% |
| 30 Sep, 20 | 142 | -10.69% | 56,446,120 | 23.67% | 68.94% | 1.81% | 66 | -30.53% | 37 | 37.04% |
| 30 Jun, 20 | 159 | 34.75% | 45,644,278 | 29.17% | 61.78% | 2.37% | 95 | 26.67% | 27 | 68.75% |
| 31 Mar, 20 | 118 | 6.31% | 35,337,472 | 14.22% | 51.01% | 2.18% | 75 | 53.06% | 16 | -44.83% |
| 31 Dec, 19 | 111 | 0.91% | 30,938,384 | -3.06% | 48.42% | 1.99% | 49 | 25.64% | 29 | -17.14% |
| 30 Sep, 19 | 110 | -1.79% | 31,914,216 | -1.43% | 49.36% | 1.96% | 39 | -23.53% | 35 | 16.67% |
| 30 Jun, 19 | 112 | 0.90% | 32,375,916 | 36.98% | 50.16% | 3.42% | 51 | -23.88% | 30 | 87.50% |
| 31 Mar, 19 | 111 | 20.65% | 23,635,390 | -8.86% | 38.32% | 1.87% | 67 | 71.79% | 16 | -27.27% |
| 31 Dec, 18 | 92 | -3.16% | 25,933,958 | 18.05% | 45.31% | 3.07% | 39 | - | 22 | - |
| 30 Sep, 18 | 95 | 5.56% | 21,968,398 | -9.98% | 38.39% | 2.11% | 39 | -18.75% | 22 | 15.79% |
| 30 Jun, 18 | 90 | 4.65% | 24,405,066 | 3.58% | 42.70% | 2.44% | 48 | 2.13% | 19 | 18.75% |
| 31 Mar, 18 | 86 | -7.53% | 23,562,012 | 11.42% | 41.80% | 2.35% | 47 | -20.34% | 16 | - |
| 31 Dec, 17 | 93 | 25.68% | 21,146,303 | 38.43% | 42.14% | 4.56% | 59 | 51.28% | 16 | -5.88% |
| 30 Sep, 17 | 74 | -2.63% | 15,275,442 | -4.28% | 30.42% | 3.01% | 39 | -18.75% | 17 | 142.86% |
| 30 Jun, 17 | 76 | 11.76% | 15,958,319 | 13.93% | 31.79% | 3.49% | 48 | 17.07% | 7 | -30.00% |
| 31 Mar, 17 | 68 | 21.43% | 14,007,167 | 7.63% | 30.20% | 3.02% | 41 | 13.89% | 10 | 25.00% |
| 31 Dec, 16 | 56 | 33.33% | 13,013,996 | 10.31% | 31.64% | 4.36% | 36 | 12.50% | 8 | 100.00% |
| 30 Sep, 16 | 42 | 68.00% | 11,797,557 | 15.26% | 26.95% | 3.86% | 32 | 68.42% | 4 | 100.00% |
| 30 Jun, 16 | 25 | 13.64% | 10,235,984 | 97.88% | 26.42% | 13.96% | 19 | 137.50% | 2 | -50.00% |
| 31 Mar, 16 | 22 | - | 5,172,793 | 3.33% | 13.76% | 7.76% | 8 | - | 4 | -20.00% |
| 31 Dec, 15 | 22 | 15.79% | 5,006,201 | -46.78% | 13.31% | 1.82% | 8 | -50.00% | 5 | 150.00% |
| 30 Sep, 15 | 19 | 35.71% | 9,406,757 | 203.62% | 27.05% | 20.40% | 16 | 14.29% | 2 | - |
| 30 Jun, 15 | 14 | - | 3,098,233 | - | 11.52% | - | 14 | - | - | - |
Corbus Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Corbus Pharmaceuticals's stock was made by Moran Sean F. on Jun 18 2024, selling 7,788 shares at $49.87 per share (valued at $388.42K).
Corbus Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 27 | 20 | 135.00% |
| Q1 2024 | 33 | 2 | 1650.00% |
| Q2 2023 | 7 | - | - |
| Q1 2023 | 5 | - | - |
| Q3 2022 | 3 | - | - |
| Q2 2022 | 10 | - | - |
| Q1 2022 | 7 | - | - |
| Q4 2021 | 1 | - | - |
| Q2 2021 | 5 | - | - |
| Q1 2021 | 4 | - | - |
| Q4 2020 | 4 | 6 | 66.67% |
| Q3 2020 | 1 | - | - |
| Q2 2020 | 6 | - | - |
| Q1 2020 | 10 | - | - |
| Q4 2019 | 4 | - | - |
| Q3 2019 | 6 | 3 | 200.00% |
| Q2 2019 | 11 | - | - |
| Q1 2019 | 11 | - | - |
| Q4 2018 | 1 | 1 | 100.00% |
| Q2 2018 | 11 | 1 | 1100.00% |
27 total buy trades, and 20 total sell trades (buy/sell ratio of 1.35%) were made by Corbus Pharmaceuticals's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 7 | - |
| Q1 2024 | 25 | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q3 2022 | 3 | - | - |
| Q2 2022 | 2 | - | - |
| Q1 2022 | 3 | - | - |
| Q4 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | 1 | 3 | 33.33% |
| Q3 2020 | - | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | 4 | - | - |
| Q4 2019 | 4 | - | - |
| Q3 2019 | 5 | - | - |
| Q2 2019 | 4 | - | - |
| Q1 2019 | 6 | - | - |
| Q4 2018 | - | - | - |
| Q2 2018 | 4 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 7 open market sell trades of Corbus Pharmaceuticals's stocks.
Corbus Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| ZVSA | ZyVersa Therapeutics, Inc. |
| CUE | Cue Biopharma, Inc. |
| XFOR | X4 Pharmaceuticals, Inc. |
| VECT | VectivBio Holding AG |
| MREO | Mereo BioPharma Group plc |
| NXTC | NextCure, Inc. |
| BCAB | BioAtla, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| CTMX | CytomX Therapeutics, Inc. |
| SPRO | Spero Therapeutics, Inc. |
| GLMD | Galmed Pharmaceuticals Ltd. |
| INZY | Inozyme Pharma, Inc. |
| ANTX | AN2 Therapeutics, Inc. |
| ADVM | Adverum Biotechnologies, Inc. |
| AFMD | Affimed N.V. |
| ASMB | Assembly Biosciences, Inc. |
| KOD | Kodiak Sciences Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| OCEA | Ocean Biomedical, Inc. |
| TRVI | Trevi Therapeutics, Inc. |
| NLTX | Neurogene Inc. |
| LIFE | aTyr Pharma, Inc. |
| ZURA | Zura Bio Limited |
| ELEV | Elevation Oncology, Inc. |
CRBP Ownership FAQ
Who Owns Corbus Pharmaceuticals?
Corbus Pharmaceuticals is owned by institutional shareholders (0.00%), insiders (0.76%), and public (99.24%). The largest institutional shareholder of Corbus Pharmaceuticals is IFP ADVISORS, INC (0% of total shares) and the top mutual fund owner is AMERICAN GROWTH FUND INC (6.14% of total shares).
Who are the major institutional shareholders of Corbus Pharmaceuticals?
Corbus Pharmaceuticals's major institutional shareholders are IFP ADVISORS, INC. The top five shareholders own together 0% of the company's share outstanding.
How many Corbus Pharmaceuticals shareholders are there?
As of Mar 2023, there are 1 institutional shareholders of Corbus Pharmaceuticals.
What percentage of Corbus Pharmaceuticals is owned by IFP ADVISORS, INC?
IFP ADVISORS, INC owns 0 shares of Corbus Pharmaceuticals, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2023).